Cartesian Therapeutics Inc.

09/09/2024 | Press release | Distributed by Public on 09/09/2024 12:58

Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis